Welcome!

News Feed Item

Medidata Reports Record Second Quarter 2014 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the second quarter of 2014 and reiterated its revenue guidance.

“Medidata’s track record of strong growth, profitability and successful innovation gives us great confidence in our future ability to grow and extend our lead in the industry,” said Tarek Sherif, Medidata's chairman and chief executive officer. “Our market opportunity is significant and we are successfully executing on our near- and long-term plan. Reflecting on Medidata’s performance this quarter, we continue to benefit from many of the same positive trends we have seen over the past 18 months, including an improving funding environment for biotechnology companies and increased focus on improving drug development efficiency. We see this reflected in increased deal activity, new customer wins and greater multi-product adoption. Our ability to innovate and expand the breadth and relevance of our platform is fueling greater interest and awareness of our solutions across the globe and is contributing to our growing pipeline of opportunities.”

Second Quarter 2014 Results

  • Total revenues for the second quarter of 2014 were $83.2 million, an increase of $15.1 million, or 22%, compared with $68.1 million in 2013. Subscription revenue was $68.9 million, an increase of 22% compared with the same period last year.
  • GAAP operating income for the quarter was $7.1 million, compared with $8.8 million in the second quarter of 2013. Non-GAAP operating income* for the second quarter of 2014 was $18.4 million, compared with $17.5 million a year ago.
  • GAAP net income for the second quarter of 2014 was $2.3 million, or $0.04 per diluted share, compared with $5.1 million, or $0.09 per diluted share, in the second quarter of 2013. Adjusted non-GAAP net income* for the second quarter of 2014 was $9.4 million, or $0.17 per diluted share, compared with $9.5 million, or $0.18 per diluted share, in the second quarter of 2013. See the non-GAAP reconciliation included in this release for full details of the non-GAAP adjustments.
  • Total cash, cash equivalents and marketable securities were $418.5 million at the end of the second quarter of 2014, an increase of $278.1 million, or 198%, compared with $140.4 million at the end of the second quarter of 2013, primarily due to net proceeds from the convertible senior notes issued during 2013 and strong cash flows over the past year.
  • Cash flow from operations was $24.1 million in the second quarter of 2014, compared with $26.2 million a year ago.

Additional Highlights

  • Medidata’s customer base grew to 437, with 30 new clients added in the second quarter of 2014, an increase of 50% over the number of new clients added in the second quarter of 2013.
  • 54% of customers had committed to multiple products at the end of the second quarter of 2014, up from 45% at the end of the second quarter of 2013.
  • Partners continue to increase their commitments to Medidata for their technology outsourcing, with 2 top CROs signing enterprise deals. Partners also extended their ability to service non-Rave solutions, with accreditations for Medidata Patient Cloud™ as well as other solutions.
  • Billings were $78 million in the second quarter of 2014, a 19% increase over the second quarter of 2013.
  • Subscription backlog for the remainder of the year as of June 30, 2014 increased to $133 million, an increase of $23 million year over year. Remaining subscription backlog does not include revenues associated with intra-year renewals of $2 million.
  • Medidata's overall revenue retention rate was nearly 100%.

“Our strong second quarter results are highlighted by solid, profitable growth, record cash collections and stellar renewal activity,” said Cory Douglas, Medidata’s chief financial officer. “I am particularly pleased with the strength of our execution and disciplined strategic investments in the quarter. Looking ahead, we see an acceleration of subscription revenue growth and record profitability in the second half of the year.”

Financial Outlook

For the full year 2014, the company expects:

  • Revenues between $340.0 and $345.0 million.
  • Professional services revenues in the mid $50.0 million range.
  • Non-GAAP operating income between $80.0 and $83.0 million. Based on current estimates, this would equate to GAAP operating income between $28.5 and $31.5 million.**
  • Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $41.0 and $44.0 million. Based on current estimates, this would equate to GAAP net income between $9.0 and $12.0 million.**
  • While changes in the stock price could change the fully diluted share count, the company is assuming 55.1 million fully diluted shares.

**The current estimated GAAP equivalents to our Non-GAAP guidance reflect the impact of approximately $5.0 million on a pre-tax basis of additional stock based compensation expenses relative to our prior outlook.

Conference Call

The company plans to host its investor conference call today at 8:00 a.m. Eastern. The investor conference call will be available via live webcast on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. To participate by telephone, domestic participants may dial 877-303-2528 and international participants may dial 847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register. Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. A replay of the conference call can be accessed until Tuesday, August 12, 2014, by dialing 800-585-8367 domestically or 404-537-3406 internationally, with the passcode 72083877. An archive of the call will also be hosted on the “Investor” section of Medidata’s web site, http://investor.mdsol.com, for a limited period of time.

About Medidata

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Cautionary Statement

Certain statements made in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve significant risks and uncertainties about Medidata Solutions, Inc. (“Medidata”), including but not limited to statements about Medidata’s forecast of financial performance, products and services, business model, strategy and growth opportunities, and competitive position. Such statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in these statements. In particular, the risks and uncertainties include, among other things, risks associated with possible fluctuations in our financial and operating results; errors, interruptions or delays in our service or our Web hosting; the financial impact of any future acquisitions; our ability to continue to release, and gain customer acceptance of, new and improved versions of our products; changes in our sales and implementation cycles; competition; our ability to retain and expand our customer base or increase new business from those customers; our ability to hire, retain and motivate our employees and manage our growth; regulatory developments; litigation; and general developments in the economy. For additional disclosure regarding these and other risks faced by the company, see disclosures contained in Medidata’s public filings with the Securities and Exchange Commission including, the “Risk Factors” section of Medidata’s Annual Report on Form 10-K for the year ended December 31, 2013. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof, and Medidata undertakes no obligation to update such statements as a result of new information.

*Non-GAAP Financial Information

Medidata provides non-GAAP operating income, net income and net income per share applicable to common stockholders data as additional information for its operating results. These measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and an adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax-affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, an adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes. Management uses these non-GAAP measures to evaluate its financial results, develop budgets, manage expenditures, and as an important factor in determining variable compensation. In addition, investors frequently have requested information from management regarding depreciation, amortization and other non-cash charges, such as share-based compensation, and management believes, based on discussions with investors, that these non-GAAP measures enhance investors’ ability to assess Medidata’s historical and projected future financial performance. While management believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of non-GAAP financial measures. One limitation of non-GAAP operating income is that it excludes depreciation and amortization, which represents the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in our business. Medidata compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to the comparable GAAP results, which are attached to this press release.

       
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(Amounts in thousands, except per share data)
Three Months Ended

June 30,

Six Months Ended

June 30,

2014 2013 2014 2013
Revenues
Subscription $ 68,947 $ 56,346 $ 132,758 $ 106,998
Professional services 14,276   11,723   27,105   24,330  
Total revenues 83,223 68,069 159,863 131,328
Cost of revenues (1)(2)
Subscription 11,221 8,949 22,307 17,974
Professional services 9,753   7,971   19,466   16,075  
Total cost of revenues 20,974 16,920 41,773 34,049
Gross profit 62,249 51,149 118,090 97,279
Operating costs and expenses:
Research and development (1) 17,311 12,105 35,100 24,010
Sales and marketing (1)(2) 20,425 16,253 41,157 30,742
General and administrative (1) 17,373   13,955   34,419   26,599  
Total operating costs and expenses 55,109   42,313   110,676   81,351  
Operating income 7,140 8,836 7,414 15,928
Interest and other (expense) income:
Interest expense (3,827 ) (27 ) (7,608 ) (45 )
Interest income 420 59 815 135
Other (expense) income, net (28 ) (10 ) 6   144  
Total interest and other (expense) income, net (3,435 ) 22   (6,787 ) 234  
Income before income taxes 3,705 8,858 627 16,162
Provision for income taxes 1,409   3,752   146   5,356  
Net income $ 2,296   $ 5,106   $ 481   $ 10,806  
Earnings per share:
Basic (3) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
Diluted (3) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Weighted average common shares outstanding:
Basic (3) 52,457 50,850 52,284 50,546
Diluted (3) 54,828 53,488 54,998 53,056
(1) Stock-based compensation expense included in cost of revenues and operating costs and expenses is as follows:
Cost of revenues $ 1,027 $ 838 $ 2,099 $ 1,325
Research and development 817 627 1,729 1,085
Sales and marketing 1,060 1,722 3,411 2,944
General and administrative 5,726   3,937   11,090   6,975  
Total stock-based compensation $ 8,630   $ 7,124   $ 18,329   $ 12,329  
(2) Amortization expense of intangible assets included in costs of revenues and operating costs and expenses is as follows:
Cost of revenues $ 111 $ 101 $ 219 $ 382
Sales and marketing 30   33   60   146  
Total amortization of intangible assets $ 141   $ 134   $ 279   $ 528  
(3) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

       
MEDIDATA SOLUTIONS, INC.
Reconciliation of GAAP Operating Income and GAAP Net Income to

Non-GAAP Operating Income and Adjusted Non-GAAP Net Income (Unaudited)

(Amounts in thousands, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2014 2013 2014 2013
Operating income:
GAAP operating income $ 7,140 $ 8,836 $ 7,414 $ 15,928
GAAP operating margins 8.6 % 13.0 % 4.6 % 12.1 %
Stock-based compensation 8,630 7,124 18,329 12,329
Depreciation and amortization 2,609 1,473 5,144 3,324
Contingent consideration adjustment (1)   60     120  
Non-GAAP operating income $ 18,379   $ 17,493   $ 30,887   $ 31,701  
Non-GAAP operating margins 22.1 % 25.7 % 19.3 % 24.1 %
Net income:
GAAP net income $ 2,296 $ 5,106 $ 481 $ 10,806
Stock-based compensation 8,630 7,124 18,329 12,329
Amortization 141 134 279 528
Contingent consideration adjustment (1) 60 120
Non-cash interest expense on convertible senior notes (2) 3,102 6,162
Tax impact on add-back items (3) (4,749 ) (2,927 ) (9,908 ) (5,191 )
Adjusted non-GAAP net income $ 9,420   $ 9,497   $ 15,343   $ 18,592  
GAAP basic earnings per share (4) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
GAAP diluted earnings per share (4) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Adjusted Non-GAAP basic earnings per share (4) $ 0.18   $ 0.19   $ 0.29   $ 0.37  
Adjusted Non-GAAP diluted earnings per share (4) $ 0.17   $ 0.18   $ 0.28   $ 0.35  
(1) Amount represents the effect of changes in fair value of contingent consideration liability.
(2) During the third quarter of 2013, we issued $287.5 million in convertible senior notes (the "Notes") with a coupon interest rate of 1.00%. Interest is paid semiannually on February 1 and August 1 over the five-year term of the notes. In connection with the Notes, we are required to recognize non-cash interest expense, including amortization of debt discount and issuance costs, in accordance with accounting guidance for convertible debt that may be settled in cash. We exclude this incremental non-cash interest expense for purposes of calculating adjusted non-GAAP net income. We believe that excluding these expenses from our non-GAAP measures is useful to investors because such incremental non-cash interest expense does not generate a cash outflow for the company and the debt issuance costs do not represent a cash outflow for the company except in the period the Notes were issued; therefore both are not indicative of our continuing operations or meaningful when comparing current results to past results.
(3) Tax impact calculated using a 40% tax rate.
(4) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

The table above presents a reconciliation of GAAP to non-GAAP operating income, net income, and net income per share applicable to common stockholders for the three and six months ended June 30, 2014 and 2013. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes.

 

   
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(Amounts in thousands, except per share data)
June 30, 2014 December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents $ 35,192 $ 22,328
Marketable securities 183,000 218,892
Accounts receivable, net of allowance for doubtful accounts of $1,231 and $1,055, respectively 61,971 45,534
Prepaid commission expense 3,495 3,615
Prepaid expenses and other current assets 14,440 13,511
Deferred income taxes 669   665  
Total current assets 298,767 304,545
Restricted cash 5,118 5,118
Furniture, fixtures and equipment, net 41,237 41,229
Marketable securities, long-term 200,283 195,105
Goodwill 15,655 15,487
Intangible assets, net 650 904
Deferred income taxes, long-term 356 345
Other assets 9,161   10,620  
Total assets $ 571,227   $ 573,353  
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 5,283 $ 7,524
Accrued payroll and other compensation 10,654 27,773
Accrued expenses and other 9,686 12,265
Deferred revenue 57,909   52,628  
Total current liabilities 83,532   100,190  
Noncurrent liabilities:
Convertible 1.00% senior notes, net 235,228 229,705
Deferred revenue, less current portion 440 1,430
Deferred tax liabilities 2,588 5,651
Other long-term liabilities 15,205   10,564  
Total noncurrent liabilities 253,461   247,350  
Total liabilities 336,993   347,540  
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $0.01 per share; 5,000 shares authorized, none issued and outstanding
Common stock, par value $0.01 per share; 100,000 shares authorized, 55,817 and 55,018 shares issued; 54,002 and 53,634 shares outstanding, respectively 558 550
Additional paid-in capital 273,664 248,336
Treasury stock, 1,815 and 1,384 shares, respectively (44,513 ) (26,414 )
Accumulated other comprehensive income (loss) 504 (199 )
Retained earnings 4,021   3,540  
Total stockholders' equity 234,234   225,813  
Total liabilities and stockholders' equity $ 571,227   $ 573,353  
 

 
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(Amounts in thousands)
Six Months Ended June 30,
2014   2013
Cash flows from operating activities:
Net income $ 481 $ 10,806
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 5,144 3,324
Stock-based compensation 18,329 12,329
Amortization of discounts or premiums on marketable securities 2,714 1,001
Deferred income taxes (3,146 ) 3,883
Amortization of debt issuance costs 639 30
Amortization of debt discount 5,523
Excess tax benefit associated with equity awards (2,648 ) (997 )
Contingent consideration adjustment 120
Provision for doubtful accounts 266 657
Changes in operating assets and liabilities:
Accounts receivable (18,328 ) 3,274
Prepaid commission expense 657 (830 )
Prepaid expenses and other current assets 1,018 1,153
Other assets 87 (78 )
Accounts payable 2,476 (900 )
Accrued payroll and other compensation (7,134 ) (2,338 )
Accrued expenses and other 5,437 1,183
Deferred revenue 3,588 (4,140 )
Other long-term liabilities 2,711   591  
Net cash provided by operating activities 17,814   29,068  
Cash flows from investing activities:
Purchase of furniture, fixtures and equipment (11,602 ) (6,761 )
Purchase of available-for-sale marketable securities (113,019 ) (78,255 )
Proceeds from sale of available-for-sale marketable securities 141,214 65,272
Net decrease in restricted cash 226   388  
Net cash provided by (used in) investing activities 16,819   (19,356 )
Cash flows from financing activities:
Proceeds from exercise of stock options 1,885 6,150
Proceeds from employee stock purchase plan 2,513
Excess tax benefit associated with equity awards 2,648 997
Payment of acquisition-related earn-out (704 ) (380 )
Repayment of obligations under capital leases (39 ) (27 )
Acquisition of treasury stock (28,058 ) (10,461 )
Repayment of notes payable (85 ) (38 )
Net cash used in financing activities (21,840 ) (3,759 )
Net increase in cash and cash equivalents 12,793 5,953
Effect of exchange rate changes on cash and cash equivalents 71 (76 )
Cash and cash equivalents - Beginning of period 22,328   32,683  
Cash and cash equivalents - End of period $ 35,192   $ 38,560  
 

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Commvault, a global leader in enterprise data protection and information management, has been named “Bronze Sponsor” of SYS-CON's 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Commvault is a leading provider of data protection and information management solutions, helping companies worldwide activate their data to drive more value and business insight and to transform moder...
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). Download Slide Deck: ▸ Here In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discusse...
Whether they’re located in a public, private, or hybrid cloud environment, cloud technologies are constantly evolving. While the innovation is exciting, the end mission of delivering business value and rapidly producing incremental product features is paramount. In his session at @DevOpsSummit at 19th Cloud Expo, Kiran Chitturi, CTO Architect at Sungard AS, will discuss DevOps culture, its evolution of frameworks and technologies, and how it is achieving maturity. He will also cover various st...
SYS-CON Events announced today that eCube Systems, a leading provider of middleware modernization, integration, and management solutions, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. eCube Systems offers a family of middleware evolution products and services that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of So...
Digital innovation is the next big wave of business transformation based on digital technologies of which IoT and Big Data are key components, For example: Business boundary innovation is a challenge to excavate third-party business value using IoT and BigData, like Nest Business structure innovation may propose re-building business structure from scratch, as Uber does in the taxicab industry The social model innovation is also a big challenge to the new social architecture with the design fr...
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
What are the new priorities for the connected business? First: businesses need to think differently about the types of connections they will need to make – these span well beyond the traditional app to app into more modern forms of integration including SaaS integrations, mobile integrations, APIs, device integration and Big Data integration. It’s important these are unified together vs. doing them all piecemeal. Second, these types of connections need to be simple to design, adapt and configure...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, wh...
Data is an unusual currency; it is not restricted by the same transactional limitations as money or people. In fact, the more that you leverage your data across multiple business use cases, the more valuable it becomes to the organization. And the same can be said about the organization’s analytics. In his session at 19th Cloud Expo, Bill Schmarzo, CTO for the Big Data Practice at EMC, will introduce a methodology for capturing, enriching and sharing data (and analytics) across the organizati...
SYS-CON Events has announced today that Roger Strukhoff has been named conference chair of Cloud Expo and @ThingsExpo 2016 Silicon Valley. The 19th Cloud Expo and 6th @ThingsExpo will take place on November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. "The Internet of Things brings trillions of dollars of opportunity to developers and enterprise IT, no matter how you measure it," stated Roger Strukhoff. "More importantly, it leverages the power of devices and the Interne...
SYS-CON Events announced today that Bsquare has been named “Silver Sponsor” of SYS-CON's @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. For more than two decades, Bsquare has helped its customers extract business value from a broad array of physical assets by making them intelligent, connecting them, and using the data they generate to optimize business processes.
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
We’ve been doing it for years, decades for some. How many websites have you created accounts on? Your bank, your credit card companies, social media sites, hotels and travel sites, online shopping sites, and that’s just the start. We do it often without even thinking about it, quickly entering our personal information, our data, in a plethora of systems. Sometimes we’re not even aware of the information we are providing. It could be very personal information (think of the security questions you ...
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lea...